Table 1.
Patient characteristics | Number of patients (n = 62) |
---|---|
Sex | |
Male | 36 (58.1%) |
Female | 26 (41.9%) |
Age (years) | |
Median | 3.5 (1.0–22.0) |
Location | |
Infratentorial | 41 (66.1%) |
Supratentorial | 21 (33.9%) |
Grade | |
II | 18 (29.0%) |
III | 44 (71.0%) |
Tumour size | |
Grade II | |
Median (cm3) | 38.29 (1.6–173.4) |
Grade III | |
Median (cm3) | 57.374 (1.53–285.2) |
Initial CE lesion volume | |
Grade-II lesions with CE | 14 |
Median (cm3) | 12.20 (0–31.67) |
Grade-III lesions with CE | 42 |
Median (cm3) | 14.91 (0–71.45) |
Initial NE lesion volume | |
Grade-II lesions with NE | 17 |
Median (cm3) | 20.83 (0–141.72) |
Grade-III lesions with NE | 44 |
Median (cm3) | 38.38 (3.83–262.53) |
Extent of resection | |
Gross Total Resection | 51 (82.3%) |
Sub Total Resection | 11 (17.7%) |
Chemotherapy | |
Yes | 16 (25%) |
No | 46 (74%) |
Dose (Gy) | 59.4 (50.4–59.4) |
Number of treatment centres | 12 |
CE, contrast-enhancing; NE, non-enhancing.